| Literature DB >> 18947430 |
Charlotte Devereaux Walsh1, Aradhana Gera, Meeraj Shah, Amit Sharma, Judy E Powell, Sue Wilson.
Abstract
BACKGROUND: Human Papilloma Virus (HPV) vaccine has undergone successful trials and has recently been approved for use for the primary prevention of cervical cancer. The aim of this study was to determine knowledge and attitudes towards HPV vaccination.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18947430 PMCID: PMC2579427 DOI: 10.1186/1471-2458-8-368
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Characteristics of participants
| Ladywood | 140 | 33.3 | |
| Northfield | 140 | 33.3 | |
| Sutton Coldfield | 140 | 33.3 | |
| 16–24 | 110 | 26.2 | |
| 25–34 | 91 | 21.7 | |
| 35–44 | 126 | 30.0 | |
| 45–54 | 93 | 22.1 | |
| Male | 159 | 37.9 | |
| Female | 261 | 62.1 | |
| White British and Irish | 305 | 72.6 | |
| Mixed | 13 | 3.1 | |
| Asian (Indian, Pakistani, Bangladeshi or other) | 54 | 12.9 | |
| Black (Black African, Black Caribbean or other) | 37 | 8.8 | |
| Other (including Chinese) | 11 | 2.6 | |
| I | 9 | 2.1 | |
| II | 67 | 16.0 | |
| IIIN | 109 | 26.0 | |
| IIIM | 56 | 13.3 | |
| IV | 61 | 14.5 | |
| V | 118 | 28.1 | |
| Yes | 248 | 59.0 | |
| No | 172 | 41.0 | |
Knowledge scores by ethnicity, social class; age and gender
| Mean score | SD | p-value* | |||||||
| White | N | 235 | 30 | 13 | 13 | 14 | 0.61 | 1.416 | |
| % | 77.0 | 9.8 | 4.3 | 4.3 | 4.6 | ||||
| Non-White | N | 105 | 4 | 1 | 2 | 3 | 0.26 | 1.035 | 0.001 |
| % | 91.3 | 3.5 | 0.9 | 1.7 | 2.6 | ||||
| Non-manual (I-IIIN) | N | 128 | 22 | 8 | 12 | 15 | 0.90 | 1.745 | |
| % | 69.2 | 11.9 | 4.3 | 6.5 | 8.1 | ||||
| Manual (IIIM-V) | N | 212 | 12 | 6 | 3 | 2 | 0.20 | 0.742 | <0.001 |
| % | 90.2 | 5.1 | 2.6 | 1.3 | 0.9 | ||||
| 16–24 | N | 96 | 8 | 3 | 2 | 1 | 0.25 | 0.826 | |
| % | 87.3 | 7.3 | 2.7 | 1.8 | 0.9 | ||||
| 24–34 | N | 73 | 9 | 3 | 4 | 2 | 0.44 | 1.128 | |
| % | 80.2 | 9.9 | 3.3 | 4.4 | 2.2 | ||||
| 34–44 | N | 104 | 7 | 4 | 5 | 6 | 0.52 | 1.390 | |
| % | 82.5 | 5.6 | 3.2 | 4.0 | 4.8 | ||||
| 44–54 | N | 67 | 10 | 4 | 4 | 8 | 0.86 | 1.779 | 0.034 |
| % | 72.0 | 10.8 | 4.3 | 4.3 | 8.6 | ||||
| Male | N | 136 | 12 | 3 | 4 | 4 | 0.35 | 1.091 | |
| % | 85.5 | 7.5 | 1.9 | 2.5 | 2.5 | ||||
| Female | N | 204 | 22 | 11 | 11 | 13 | 0.61 | 1.450 | 0.05 |
| % | 78.2 | 8.4 | 4.2 | 4.2 | 5.0 | ||||
* derived from Kruskall-Wallis test for age; Mann-Whitney U test for other factors
Attitude by ethnicity, social class; age and gender
| Mean score | SD | p-value* | |||||||
| White | N | 80 | 197 | 15 | 11 | 2 | 1.88 | 0.71 | |
| % | 26.2 | 64.6 | 4.9 | 3.6 | 0.7 | ||||
| Non-White | N | 21 | 72 | 10 | 10 | 2 | 2.13 | 0.87 | 0.006 |
| % | 18.3 | 62.6 | 8.7 | 8.7 | 1.7 | ||||
| Non-manual (I-IIIN) | N | 41 | 123 | 9 | 10 | 2 | 1.97 | 0.77 | |
| % | 22.2 | 66.5 | 4.9 | 5.4 | 1.1 | ||||
| Manual (IIIM-V) | N | 60 | 146 | 16 | 11 | 2 | 1.93 | 0.77 | 0.62 |
| % | 25.5 | 62.1 | 6.8 | 4.7 | 0.9 | ||||
| 16–24 | N | 27 | 73 | 7 | 3 | 0 | 1.87 | 0.64 | |
| % | 24.5 | 66.4 | 6.4 | 2.7 | 0.0 | ||||
| 24–34 | N | 26 | 55 | 4 | 6 | 0 | 1.89 | 0.77 | |
| % | 28.6 | 60.4 | 4.4 | 6.6 | 0.0 | ||||
| 34–44 | N | 19 | 88 | 11 | 6 | 2 | 2.08 | 0.76 | |
| % | 15.1 | 69.8 | 8.7 | 4.8 | 1.6 | ||||
| 44–54 | N | 29 | 53 | 3 | 6 | 2 | 1.91 | 0.89 | 0.047 |
| % | 31.2 | 57.0 | 3.2 | 6.5 | 2.2 | ||||
| Male | N | 38 | 104 | 11 | 3 | 3 | 1.92 | 0.74 | |
| % | 23.9 | 65.4 | 6.9 | 1.9 | 1.9 | ||||
| Female | N | 63 | 165 | 14 | 18 | 1 | 1.96 | 0.78 | 0.769 |
| % | 24.1 | 63.2 | 5.4 | 6.9 | 0.4 | ||||
* derived from Kruskall-Wallis test for age; Mann-Whitney U test for other factors.
ATTITUDE:
1 = STRONGLY AGREE.
2 = AGREE.
3 = NO OPINION.
4 = DISAGREE.
5 = STRONGLY DISAGREE.
Attitude assessed by the question: "Do you think that the introduction of HPV vaccination is a good idea?
HPV related information provided to participants
| • Most cervical cancer is caused by HPV infection. |
| • HPV is a sexually transmitted infection that can affects both males and females. |
| • The vaccine protects against HPV infection. |
| • The government is considering introducing the vaccination. |
| • Like rubella, the HPV vaccination will be a school based vaccination programme and be given to girls between 10 – 12 years. |
| • Vaccination only effective in people that have not yet been infected with HPV. |